SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $202,972 | +102.5% | 203,000 | +97.1% | 0.00% | – |
| Q4 2022 | $100,250 | +1153.1% | 103,000 | +1187.5% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -50.0% | 8,000 | -50.0% | 0.00% | – |
| Q3 2021 | $16,000 | -70.9% | 16,000 | -71.4% | 0.00% | – |
| Q2 2021 | $55,000 | +1.9% | 56,000 | 0.0% | 0.00% | – |
| Q1 2021 | $54,000 | 0.0% | 56,000 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +5.9% | 56,000 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | +628.6% | 56,000 | +600.0% | 0.00% | – |
| Q2 2020 | $7,000 | – | 8,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |